Objective. To compare the distribution of congenital anomalies within the VACTERL association (vertebral defects, anal atresia, cardiac, tracheoesophageal, renal, and limb abnormalities) between patients exposed to tumor necrosis factor-α (TNF-α) antagonist and the general population. Methods. Analysis for comparison of proportional differences to a previous publication between anomaly subgroups, according to subgroup definitions of the European Surveillance of Congenital Anomalies (EUROCAT), a population-based database. Results. Most EUROCAT subgroups belonging to the VACTERL association contained only one or 2 records of TNF-α antagonist exposure, so comparison of proportions was imprecise. Only the category "limb abnormalities" showed a significantly higher proportion in the general population. Conclusion. The high number of congenital anomalies belonging to the VACTERL association from a report of pregnancies exposed to TNF-α antagonists could not be confirmed using a population-based congenital anomaly database. The Journal of Rheumatology Copyright

, , , ,
doi.org/10.3899/jrheum.101316, hdl.handle.net/1765/74999
Journal of Rheumatology
Department of Medical Informatics

Crijns, H. J. M. J., Jentink, J., Garne, E., Gispen-De Wied, C., Straus, S., & de Jong-van den Berg, L. (2011). The distribution of congenital anomalies within the VACTERL association among tumor necrosis factor antagonist-exposed pregnancies is similar to the general population. Journal of Rheumatology, 38(9), 1871–1874. doi:10.3899/jrheum.101316